Two Sigma Investments, LP Ab Cellera Biologics Inc. Transaction History

Two Sigma Investments, LP

  • $50.6 Billion
  • Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 4,110,852 shares of ABCL stock, worth $17.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,110,852
Previous 3,126,789 31.47%
Holding current value
$17.6 Million
Previous $6.97 Million 102.24%
% of portfolio
0.03%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$1.93 - $3.8 $1.9 Million - $3.74 Million
984,063 Added 31.47%
4,110,852 $14.1 Million
Q1 2025

May 15, 2025
SELL
$2.2 - $3.53 $287,148 - $460,742
-130,522 Reduced 4.01%
3,126,789 $6.97 Million
Q4 2024

Feb 14, 2025
BUY
$2.48 - $3.15 $1.79 Million - $2.28 Million
723,676 Added 28.56%
3,257,311 $9.54 Million
Q3 2024

Nov 14, 2024
BUY
$2.39 - $3.49 $1.13 Million - $1.65 Million
472,279 Added 22.91%
2,533,635 $6.56 Million
Q2 2024

Aug 14, 2024
BUY
$2.73 - $4.73 $1.58 Million - $2.75 Million
580,441 Added 39.19%
2,061,356 $6.1 Million
Q1 2024

May 15, 2024
BUY
$4.29 - $5.97 $1.77 Million - $2.46 Million
411,677 Added 38.5%
1,480,915 $6.71 Million
Q4 2023

Feb 14, 2024
SELL
$3.91 - $5.93 $501,394 - $760,427
-128,234 Reduced 10.71%
1,069,238 $6.11 Million
Q3 2023

Nov 14, 2023
BUY
$4.6 - $7.95 $617,743 - $1.07 Million
134,292 Added 12.63%
1,197,472 $5.51 Million
Q2 2023

Aug 14, 2023
BUY
$5.66 - $7.59 $1.7 Million - $2.28 Million
300,834 Added 39.46%
1,063,180 $6.87 Million
Q1 2023

May 15, 2023
SELL
$7.31 - $11.18 $1.45 Million - $2.22 Million
-198,366 Reduced 20.65%
762,346 $5.75 Million
Q4 2022

Feb 14, 2023
SELL
$9.48 - $14.52 $2.27 Million - $3.48 Million
-239,826 Reduced 19.98%
960,712 $9.73 Million
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $4.35 Million - $6.47 Million
472,616 Added 64.93%
1,200,538 $11.9 Million
Q2 2022

Aug 15, 2022
BUY
$5.72 - $10.65 $1.33 Million - $2.47 Million
231,938 Added 46.76%
727,922 $7.75 Million
Q1 2022

May 16, 2022
SELL
$7.46 - $14.14 $146,335 - $277,370
-19,616 Reduced 3.8%
495,984 $4.84 Million
Q4 2021

Feb 14, 2022
BUY
$12.99 - $17.73 $5.61 Million - $7.65 Million
431,500 Added 513.08%
515,600 $7.37 Million
Q3 2021

Nov 15, 2021
SELL
$14.85 - $21.34 $4.35 Million - $6.26 Million
-293,116 Reduced 77.71%
84,100 $1.69 Million
Q2 2021

Aug 16, 2021
BUY
$20.19 - $34.17 $5.37 Million - $9.09 Million
265,931 Added 238.96%
377,216 $8.3 Million
Q1 2021

May 17, 2021
BUY
$23.29 - $53.2 $2.59 Million - $5.92 Million
111,285 New
111,285 $3.78 Million

Others Institutions Holding ABCL

# of Institutions
149
Shares Held
115M
Call Options Held
497K
Put Options Held
476K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $1.22B
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email